[Glaucoma in PAX6-related congenital aniridia: A review of the literature].

Glaucome de l’aniridie congénitale liée au gène PAX6 : une revue de la littérature.
Aniridie congénitale Congenital aniridia Glaucoma Glaucome Hypertonie oculaire Ocular hypertension PAX6

Journal

Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128

Informations de publication

Date de publication:
04 Oct 2024
Historique:
received: 21 02 2024
revised: 29 04 2024
accepted: 24 05 2024
medline: 6 10 2024
pubmed: 6 10 2024
entrez: 5 10 2024
Statut: aheadofprint

Résumé

PAX6-related congenital aniridia is a genetic pan-ocular disease characterized by a partial or total absence of the iris and foveal hypoplasia. The mechanisms involved in the development of ocular hypertension and glaucoma in patients with congenital aniridia are still unknown. Many hypotheses have been proposed and the advent of new anterior segment imaging techniques has allowed the identification of various potential mechanisms: congenital trabecular dysfunction, progressive closure of the iridocorneal angle, postoperative ocular hypertension. The diagnosis must take into account the various obstacles to clinical examination (corneal opacity, obturating cataract, foveolar aplasia, significant nystagmus) and is often considered only upon detection of ocular hypertension. Glaucoma remains, along with limbal insufficiency, one of the major causes of blindness in congenital aniridia. The treatment of glaucoma in congenital aniridia is primarily medical. The benefit/risk ratio of a surgical intervention should always be thoroughly evaluated in order to not underestimate the postoperative complications associated with congenital aniridia.

Identifiants

pubmed: 39368260
pii: S0181-5512(24)00245-6
doi: 10.1016/j.jfo.2024.104300
pii:
doi:

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

104300

Informations de copyright

Copyright © 2024 Elsevier Masson SAS. All rights reserved.

Auteurs

P Bastelica (P)

Service 3, hôpital national de la vision des Quinze-Vingts, IHU FOReSIGHT, 28, rue de Charenton, 75012 Paris, France; Institut de la vision, IHU FOReSIGHT, Sorbonne université, 17, rue Moreau, 75012 Paris, France.

A Daruich (A)

Faculté Paris Cité, hôpital universitaire Necker-Enfants Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France; UMRS1138, centre de recherche des Cordeliers, équipe 17, Inserm, Sorbonne université, 15, rue de l'École-de-Médecine, 75006 Paris, France.

B Paganelli (B)

Faculté Paris Cité, hôpital universitaire Necker-Enfants Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France.

A Labbé (A)

Service 3, hôpital national de la vision des Quinze-Vingts, IHU FOReSIGHT, 28, rue de Charenton, 75012 Paris, France; Institut de la vision, IHU FOReSIGHT, Sorbonne université, 17, rue Moreau, 75012 Paris, France; Hôpital Ambroise-Paré, AP-HP, université de Versailles Saint-Quentin-en-Yvelines, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.

C Baudouin (C)

Service 3, hôpital national de la vision des Quinze-Vingts, IHU FOReSIGHT, 28, rue de Charenton, 75012 Paris, France; Institut de la vision, IHU FOReSIGHT, Sorbonne université, 17, rue Moreau, 75012 Paris, France; Hôpital Ambroise-Paré, AP-HP, université de Versailles Saint-Quentin-en-Yvelines, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.

D Bremond-Gignac (D)

Faculté Paris Cité, hôpital universitaire Necker-Enfants Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France; UMRS1138, centre de recherche des Cordeliers, équipe 17, Inserm, Sorbonne université, 15, rue de l'École-de-Médecine, 75006 Paris, France. Electronic address: dominique.bremond@aphp.fr.

Classifications MeSH